Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Núñez N, Berner F, Friebel E, Unger S, Wyss N, Gomez J, Purde M, Niederer R, Porsch M, Lichtensteiger C, Kramer R, Erdmann M, Schmitt C, Heinzerling L, Abdou M, Karbach J, Schadendorf D, Zimmer L, Ugurel S, Klümper N, Hölzel M, Power L, Kreutmair S, Capone M, Madonna G, Cevhertas L, Heider A, Amaral T, Hasan Ali O, Bomze D, Dimitriou F, Diem S, Ascierto P, Dummer R, Jäger E, Driessen C, Levesque M, van de Veen W, Joerger M, Früh M, Becher B, Flatz L. Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. Med (N Y) 2023
13.01.2023Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
13.01.2023Med (N Y) 2023
Núñez Nicolás Gonzalo, Berner Fiamma, Friebel Ekaterina, Unger Susanne, Wyss Nina, Gomez Julia Martinez, Purde Mette-Triin, Niederer Rebekka, Porsch Maximilian, Lichtensteiger Christa, Kramer Rafaela, Erdmann Michael, Schmitt Christina, Heinzerling Lucie, Abdou Marie-Therese, Karbach Julia, Schadendorf Dirk, Zimmer Lisa, Ugurel Selma, Klümper Niklas, Hölzel Michael, Power Laura, Kreutmair Stefanie, Capone Mariaelena, Madonna Gabriele, Cevhertas Lacin, Heider Anja, Amaral Teresa, Hasan Ali Omar, Bomze David, Dimitriou Florentia, Diem Stefan, Ascierto Paolo Antonio, Dummer Reinhard, Jäger Elke, Driessen Christoph, Levesque Mitchell Paul, van de Veen Willem, Joerger Markus, Früh Martin, Becher Burkhard, Flatz Lukas
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.
Nuciforo P, Townend J, Piccart M, Fielding S, Gkolfi P, El-Abed S, de Azambuja E, Werutsky G, Bliss J, Moebus V, Colleoni M, Aspitia A, Gomez H, Gombos A, Coccia-Portugal M, Tseng L, Kunz G, Lerzo G, Sohn J, Semiglazov V, Saura C, Kroep J, Ferro A, Cameron D, Gelber R, Huober J, Di Cosimo S. Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer. Eur J Cancer 2022; 181:92-101.
27.12.2022Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.
27.12.2022Eur J Cancer 2022; 181:92-101
Nuciforo Paolo, Townend John, Piccart Martine, Fielding Shona, Gkolfi Panagiota, El-Abed Sarra, de Azambuja Evandro, Werutsky Gustavo, Bliss Judith, Moebus Volker, Colleoni Marco, Aspitia Alvaro Moreno, Gomez Henry, Gombos Andrea, Coccia-Portugal Maria Antonia, Tseng Ling-Ming, Kunz Georg, Lerzo Guillermo, Sohn Joohyuk, Semiglazov Vladimir, Saura Cristina, Kroep Judith, Ferro Antonella, Cameron David, Gelber Richard D, Huober Jens, Di Cosimo Serena
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
Christiansen A, Lobo J, Fankhauser C, Rothermundt C, Cathomas R, Batavia A, Grogg J, Templeton A, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. Front Oncol 2022; 12:1056823.
08.12.2022Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
08.12.2022Front Oncol 2022; 12:1056823
Christiansen Ailsa J, Lobo João, Fankhauser Christian D, Rothermundt Christian, Cathomas Richard, Batavia Aashil A, Grogg Josias B, Templeton Arnoud J, Hirschi-Blickenstorfer Anita, Lorch Anja, Gillessen Silke, Moch Holger, Beyer Jörg, Hermanns Thomas
Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancer.
Koster K, Zumstein V, Süveg K, Jochum W, Husarik D, Omlin A. Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancer. BJU Int 2022
05.12.2022Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancer.
05.12.2022BJU Int 2022
Koster Kira-Lee, Zumstein Valentin, Süveg Krisztian, Jochum Wolfram, Husarik Daniela, Omlin Aurelius
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Johnston S, Toi M, O'Shaughnessy J, Rastogi P, Campone M, Neven P, Huang C, Huober J, Jaliffe G, Cicin I, Tolaney S, Goetz M, Rugo H, Senkus E, Testa L, Del Mastro L, Shimizu C, Wei R, Shahir A, Munoz M, San Antonio B, Andre V, Harbeck N, Martín M. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol 2022
05.12.2022Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
05.12.2022Lancet Oncol 2022
Johnston Stephen R D, Toi Masakazu, O'Shaughnessy Joyce, Rastogi Priya, Campone Mario, Neven Patrick, Huang Chiun-Sheng, Huober Jens, Jaliffe Georgina Garnica, Cicin Irfan, Tolaney Sara M, Goetz Matthew P, Rugo Hope S, Senkus Elzbieta, Testa Laura, Del Mastro Lucia, Shimizu Chikako, Wei Ran, Shahir Ashwin, Munoz Maria, San Antonio Belen, Andre Valerie, Harbeck Nadia, Martín Miguel
Der Mystiker aus Nazaret
Renz M. Der Mystiker aus Nazaret - Jesuanische Spiritualität. Basel: Herder, 2022. ISBN 978-3-451-06875-1.
01.12.2022Der Mystiker aus Nazaret
01.12.2022Herder, ISBN 978-3-451-06875-1
Renz Monika
Von-Hippel-Lindau-Erkrankung
Koster K, Rothermundt C, Binet I, Borovicka J, Clerici T, Engeler D, Greiner J, Hader C, Azzarello-Burri S, Lang C, Omlin A, Krull I, Stöckli S, Hundsberger T. Von-Hippel-Lindau-Erkrankung - Interdisziplinäre Betreuung und neue therapeutische Optionen. Schweiz Aerztezeitung 2022; 48:4-784-787.
30.11.2022Von-Hippel-Lindau-Erkrankung
30.11.2022Schweiz Aerztezeitung 2022; 48:4-784-787
Koster Kira-Lee, Rothermundt Christian, Binet Isabelle, Borovicka Jan, Clerici Thomas, Engeler Daniel S, Greiner J, Hader Claudia, Azzarello-Burri Silvia, Lang C, Omlin Aurelius, Krull Ina, Stöckli Sandro, Hundsberger Thomas
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Huebner H, Ruebner M, Kurbacher C, Hadji P, Hartkopf A, Lux M, Huober J, Uhrig S, Taran F, Overkamp F, Tesch H, Häberle L, Luftner D, Wallwiener M, Müller V, Beckmann M, Hein A, Belleville E, Untch M, Janni W, Fehm T, Kolberg H, Wallwiener D, Brucker S, Schneeweiss A, Ettl J, Fasching P, Michel L. Return of individual genomic research results within the PRAEGNANT multicenter registry study. Breast Cancer Res Treat 2022
21.11.2022Return of individual genomic research results within the PRAEGNANT multicenter registry study.
21.11.2022Breast Cancer Res Treat 2022
Huebner Hanna, Ruebner Matthias, Kurbacher Christian, Hadji Peyman, Hartkopf Andreas D, Lux Michael P, Huober Jens, Uhrig Sabrina, Taran Florin-Andrei, Overkamp Friedrich, Tesch Hans, Häberle Lothar, Luftner Diana, Wallwiener Markus, Müller Volkmar, Beckmann Matthias W, Hein Alexander, Belleville Erik, Untch Michael, Janni Wolfgang, Fehm Tanja N, Kolberg Hans-Christian, Wallwiener Diethelm, Brucker Sara Y, Schneeweiss Andreas, Ettl Johannes, Fasching Peter A, Michel Laura L
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.
Rothermundt C, Andreou D, Blay J, Brodowicz T, Desar I, Dileo P, Gelderblom H, Haas R, Jakob J, Jones R, Judson I, Kunz W, Liegl-Atzwanger B, Lindner L, Messiou C, Miah A, Reichardt P, Szkandera J, van der Graaf W, van Houdt W, Wardelmann E, Hofer S. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022. Eur J Cancer 2022; 180:158-179.
16.11.2022Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.
16.11.2022Eur J Cancer 2022; 180:158-179
Rothermundt Christian, Andreou Dimosthenis, Blay Jean-Yves, Brodowicz Thomas, Desar Ingrid M E, Dileo Palma, Gelderblom Hans, Haas Rick, Jakob Jens, Jones Robin L, Judson Ian, Kunz Wolfgang G, Liegl-Atzwanger Berndadette, Lindner Lars H, Messiou Christina, Miah Aisha, Reichardt Peter, Szkandera Joanna, van der Graaf Winette T A, van Houdt Winan J, Wardelmann Eva, Hofer Silvia
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
Neuenschwander A, Lonati C, Antonelli L, Papachristofilou A, Cathomas R, Rothermundt C, Templeton A, Gulamhusein A, Fischer S, Gillessen S, Hermanns T, Lorch A, Mattei A, Fankhauser C. Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review. Eur Urol Focus 2022
12.11.2022Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
12.11.2022Eur Urol Focus 2022
Neuenschwander Anne, Lonati Chiara, Antonelli Luca, Papachristofilou Alexandros, Cathomas Richard, Rothermundt Christian, Templeton Arnoud J, Gulamhusein Aziz, Fischer Stefanie, Gillessen Silke, Hermanns Thomas, Lorch Anja, Mattei Agostino, Fankhauser Christian D
Mind-Body Online-Therapie im somatischen Setting – Entwicklung einer Online-Intervention im Rahmen der onkologischen Gynäkologie
Hämmerli Keller K, Markus A, Berger T, Huober J, Bekes I, Schmidt R, Gysin C, Schönenberger M, Germann N, Bürgin M, Diethelm S, Schmid D (2022). Mind-Body Online-Therapie im somatischen Setting – Entwicklung einer Online-Intervention im Rahmen der onkologischen Gynäkologie.
10.11.2022Mind-Body Online-Therapie im somatischen Setting – Entwicklung einer Online-Intervention im Rahmen der onkologischen Gynäkologie
10.11.2022Posterpräsentationen am den folgenden Kongressen: SAPPM SPS 2022 (Bern), SGPP 2022 (Bern)
Hämmerli Keller Katja, Markus Alexander, Berger Thomas, Huober Jens, Bekes Inga, Schmidt Roger, Gysin Christian, Schönenberger Michelle, Germann Nicolas, Bürgin Michelle, Diethelm Sarah, Schmid Dagmar
Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports.
Neff D, Padberg Sgier B, Dietze H, Müller J, Früh M. Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports. Case Rep Oncol 2022; 15:1001-1008.
08.11.2022Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports.
08.11.2022Case Rep Oncol 2022; 15:1001-1008
Neff Dominik, Padberg Sgier Barbara-Christina, Dietze Hannah, Müller Joachim, Früh Martin
Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma.
Sun S, Qi W, Rehrauer H, Ronner M, Hariharan A, Wipplinger M, Meiller C, Stahel R, Früh M, Cerciello F, Fonteneau J, Jean D, Felley-Bosco E. Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma. JTO Clin Res Rep 2022; 3:100430.
07.11.2022Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma.
07.11.2022JTO Clin Res Rep 2022; 3:100430
Sun Suna, Qi Weihong, Rehrauer Hubert, Ronner Manuel, Hariharan Ananya, Wipplinger Martin, Meiller Clément, Stahel Rolf, Früh Martin, Cerciello Ferdinando, Fonteneau Jean-François, Jean Didier, Felley-Bosco Emanuela
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.
Mucci L, Vinson J, Gold T, Gerke T, Filipenko J, Green R, Anderson S, Badal S, Bjartell A, Chi K, Davis I, Enting D, Fay A, Lazarus J, Mateo J, McDermott R, Odedina F, Olmos D, Omlin A, Popoola A, Ragin C, Roberts R, Russnes K, Waihenya C, Stopsack K, Hyslop T, Villanti P, Kantoff P, George D. IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer. JCO Glob Oncol 2022; 8:e2200154.
01.11.2022IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.
01.11.2022JCO Glob Oncol 2022; 8:e2200154
Mucci Lorelei A, Vinson Jacob, Gold Theresa, Gerke Travis, Filipenko Julie, Green Rebecca M, Anderson Simon G, Badal Simone, Bjartell Anders, Chi Kim N, Davis Ian D, Enting Deborah, Fay André P, Lazarus John, Mateo Joaquin, McDermott Raymond, Odedina Folakemi T, Olmos David, Omlin Aurelius, Popoola Ademola A, Ragin Camille, Roberts Robin, Russnes Kjell M, Waihenya Charles, Stopsack Konrad H, Hyslop Terry, Villanti Paul, Kantoff Philip, George Daniel J
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.
Fischer S, Götze T, Omlin A, Baird R, Dawson K, Zitt C, Arany Z, Tresch G, Fiedler U, Jeger S, Fung S, Legenne P, Leupin N, Schneeweiss A, Fremd C. A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab. JCO Precis Oncol 2022; 6:e2200006.
01.11.2022A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.
01.11.2022JCO Precis Oncol 2022; 6:e2200006
Fischer Stefanie, Götze Thorsten O, Omlin Aurelius, Baird Richard D, Dawson Keith M, Zitt Christof, Arany Zita, Tresch Gaby, Fiedler Ulrike, Jeger Simone, Fung Samson, Legenne Philippe, Leupin Nicolas, Schneeweiss Andreas, Fremd Carlo
Krankenbibel
Renz M. Krankenbibel - Sich selbst und Gott finden. Basel: Herder, 2022. ISBN 978-3-451-39106-4.
24.10.2022Krankenbibel
24.10.2022Herder, ISBN 978-3-451-39106-4
Renz Monika
Mutant driving the Warburg Effect in Mantle Cell lymphoma.
Kliebhan J, Besse A, Kampa-Schittenhelm K, Schittenhelm M, Driessen C. Mutant driving the Warburg Effect in Mantle Cell lymphoma. Clin Case Rep 2022; 10:e6296.
03.10.2022Mutant driving the Warburg Effect in Mantle Cell lymphoma.
03.10.2022Clin Case Rep 2022; 10:e6296
Kliebhan Johannes, Besse Andrej, Kampa-Schittenhelm Kerstin M, Schittenhelm Marcus, Driessen Christoph
Reply to Julian Chavarriaga and Robert Hamilton's Letter to the Editor re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16-8. Should We Be Afraid of Surveillance? Clinically Meaningful Reasons Why Offering Surveillance for Incidentally Detected Small Testicular Masses Remains a Safe Approach.
Pratsinis M, Rothermundt C, Fankhauser C. Reply to Julian Chavarriaga and Robert Hamilton's Letter to the Editor re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16-8. Should We Be Afraid of Surveillance? Clinically Meaningful Reasons Why Offering Surveillance for Incidentally Detected Small Testicular Masses Remains a Safe Approach. Eur Urol Open Sci 2022; 45:52.
03.10.2022Reply to Julian Chavarriaga and Robert Hamilton's Letter to the Editor re: Manolis Pratsinis, Christian Fankhauser, Katerina Pratsinis, et al. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022;40:16-8. Should We Be Afraid of Surveillance? Clinically Meaningful Reasons Why Offering Surveillance for Incidentally Detected Small Testicular Masses Remains a Safe Approach.
03.10.2022Eur Urol Open Sci 2022; 45:52
Pratsinis Manolis, Rothermundt Christian, Fankhauser Christian
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Müller-Jensen L, Zierold S, Versluis J, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank C, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel J, Ugurel S, Zimmer L, Banks P, Spain L, Soon J, Enokida T, Tahara M, Kähler K, Seggewiss-Bernhardt R, Harvey C, Long G, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French L, Knauss S, Heinzerling L. Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis. Data Brief 2022; 45:108649.
30.09.2022Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
30.09.2022Data Brief 2022; 45:108649
Müller-Jensen Leonie, Zierold Sarah, Versluis Judith M, Boehmerle Wolfgang, Huehnchen Petra, Endres Matthias, Mohr Raphael, Compter Annette, Blank Christian U, Hagenacker Tim, Meier Friedegund, Reinhardt Lydia, Gesierich Anja, Salzmann Martin, Hassel Jessica C, Ugurel Selma, Zimmer Lisa, Banks Patricia, Spain Lavinia, Soon Jennifer A, Enokida Tomohiro, Tahara Makoto, Kähler Katharina C, Seggewiss-Bernhardt Ruth, Harvey Catriona, Long Georgina V, Schöberl Florian, von Baumgarten Louisa, Hundsberger Thomas, Schlaak Max, French Lars E, Knauss Samuel, Heinzerling Lucie M
AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022.
Banys-Paluchowski M, Thill M, Kühn T, Ditsch N, Heil J, Wöckel A, Fallenberg E, Friedrich M, Kümmel S, Müller V, Janni W, Albert U, Bauerfeind I, Blohmer J, Budach W, Dall P, Fasching P, Fehm T, Gluz O, Harbeck N, Huober J, Jackisch C, Kolberg-Liedtke C, Kreipe H, Krug D, Loibl S, Luftner D, Lux M, Maass N, Mundhenke C, Nitz U, Park-Simon T, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn P, Solbach C, Solomayer E, Stickeler E, Thomssen C, Untch M, Witzel I, Gerber B. AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022. Geburtshilfe Frauenheilkd 2022; 82:1031-1043.
30.09.2022AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022.
30.09.2022Geburtshilfe Frauenheilkd 2022; 82:1031-1043
Banys-Paluchowski Maggie, Thill Marc, Kühn Thorsten, Ditsch Nina, Heil Jörg, Wöckel Achim, Fallenberg Eva, Friedrich Michael, Kümmel Sherko, Müller Volkmar, Janni Wolfgang, Albert Ute-Susann, Bauerfeind Ingo, Blohmer Jens-Uwe, Budach Wilfried, Dall Peter, Fasching Peter, Fehm Tanja, Gluz Oleg, Harbeck Nadia, Huober Jens, Jackisch Christian, Kolberg-Liedtke Cornelia, Kreipe Hans H, Krug David, Loibl Sibylle, Luftner Diana, Lux Michael Patrick, Maass Nicolai, Mundhenke Christoph, Nitz Ulrike, Park-Simon Tjoung Won, Reimer Toralf, Rhiem Kerstin, Rody Achim, Schmidt Marcus, Schneeweiss Andreas, Schütz Florian, Sinn Peter, Solbach Christine, Solomayer Erich-Franz, Stickeler Elmar, Thomssen Christoph, Untch Michael, Witzel Isabell, Gerber Bernd